DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old

MLA

Hartono Gunardi, et al. “DTwP-HB-Hib: Antibody Persistence after a Primary Series, Immune Response and Safety after a Booster Dose in Children 18–24 Months Old.” BMC Pediatrics, vol. 18, no. 1, May 2018, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s12887-018-1143-6.

APA

Hartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, Soedjatmiko, Meita Dhamayanti, Rini Sekartini, Rodman Tarigan, Hindra Irawan Satari, Bernie Endyarni Medise, Rini Mulia Sari, Novilia Sjafri Bachtiar, Cissy B. Kartasasmita, & Sri Rezeki S. Hadinegoro. (2018). DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old. BMC Pediatrics, 18(1), 1–8. https://doi.org/10.1186/s12887-018-1143-6

Chicago

Hartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, Soedjatmiko, Meita Dhamayanti, Rini Sekartini, Rodman Tarigan, et al. 2018. “DTwP-HB-Hib: Antibody Persistence after a Primary Series, Immune Response and Safety after a Booster Dose in Children 18–24 Months Old.” BMC Pediatrics 18 (1): 1–8. doi:10.1186/s12887-018-1143-6.